Sara Galimberti

Biology


Location
Italy
Gender
Female
Also Known As
Assistant Professor

Associated Professor MED/15 (Blood Diseases) Director of the school of hematology of University of Pisa. From the 1994 Prof. Galimberti followed several national trials on acute leukemia and CLL coordinated by the GIMEMA Italian Group.In the 1999-2001 she worked for the MURST project, coordinated by Prof. S. Tura on Minimal residual disease in multiple myeloma patients candidate to autologous transplantation. From the 2001, Prof. Galimberti is the scientific responsible for the molecular laboratory of the Hematology Division; this laboratory is the referee for diagnostic molecular tests for all hospitals in the West coast of Tuscany and is one of the 4 laboratories of the FIL MRD NETWORK, referee centers for the assessment of the minimal residual disease in the clinical trials coordinated by the Italian Foundation for Lymphoma Studies (FIL). Prof. Galimberti was and is involved in many clinical trials, especially in CML, according to GMP rules. In the CML setting, Prof. Galimberti is responsible of the hematological aspects of the TIKLET, ORANGE and IKAROS trials (impact of pharmacokinetics, pharmacodinamics and pharmacokinetics on the efficacy of TKIs in CML). Principal research areas: multidrug resistance, minimal residual disease, histone deacetylase inhibitors, arsenic trioxide, bortezomib, gamma delta lymphocytes, methylation, aGVHD, CML, MM, NHL.Moreover, Prof. Galimberti participated to many meetings and international congresses often as invited speaker and she is referee for several peer revised journals and editor of Frontiers in Oncology. NATIONAL COLLABORATIONS: Hematology Divisions of Modena, Reggio Calabria, Ancona, Cosenza, Catania, Roma, Perugia, Foggia, Torino, Pesaro, Bologna, Rionero in Vulture, Firenze, Siena. INTERNATIONAL COLLABORATIONS: Cytogenetic Laboratoryof the Sammelweis University (Budapest, Ungheria), molecular biology laboratory Kokaeli University, Turkey; Karolinska Institute Stockholm, Sweden; NIH (Bethesda,USA), BC Cancer Research Centre,Vancouver,BC, Canada; University of Birmingham, USA. TEACHING ACTIVITY: Genetic doctorat school 2006-2008; Neurosciences school of doctorat 2009-2011; Biological and molecular sciences school of doctorat 2009-2011; GENOMEC school of doctorat University of Siena 2012-2018; Dietistics 2005-2011; Biomedical Laboratory technicians 2002-2009; Hematology specialization school 2008-2018; Pharmacology Master 2015-2018; Master of genetics 2018 Principal investigator and sub-investigator in many clinical trials on CML, MDS, NHL, according to the GCP rules. https://www.bloomberg.com/press-releases/2021-03-18/cps-health-care-and-telewellness-present-the-rating-of-covid-technologies-on-a-lifetime-award

Voted (0)

Works (0)

Video (0)

News about Sara Galimberti(0)




Join our Telegram Channel!